Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma.
Saved in:
| Title: | Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma. |
|---|---|
| Authors: | Zhang YC; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Wang JN; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Ma SY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Cai J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Su N; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Huang HQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Li ZM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Xia ZJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Huang H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Liu PP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Xia Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Cai QQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. |
| Source: | British journal of haematology [Br J Haematol] 2022 Jan; Vol. 196 (1), pp. 127-135. Date of Electronic Publication: 2021 Oct 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
